Overview
Kimio Yonesaka practices in Osaka, Japan. Yonesaka is highly rated in 3 conditions, according to our data. Their top areas of expertise are EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Colorectal Cancer.
Their clinical research consists of co-authoring 62 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerYonesaka isDistinguished. Learn about EGFR Positive Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Yonesaka isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Lung CancerYonesaka isAdvanced. Learn about Lung Cancer.
- Experienced
- Breast CancerYonesaka isExperienced. Learn about Breast Cancer.
- Colorectal CancerYonesaka isExperienced. Learn about Colorectal Cancer.
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Lung AdenocarcinomaYonesaka isExperienced. Learn about Lung Adenocarcinoma.
- Mediastinal TumorYonesaka isExperienced. Learn about Mediastinal Tumor.
- ParonychiaYonesaka isExperienced. Learn about Paronychia.